On 26 February, Enanta Pharmaceuticals, Inc., (NASDAQ:ENTA), announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion for the use of VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA® (dasabuvir tablets) without ribavirin (RBV) in chronic hepatitis C virus (HCV) infected genotype 1b (GT1b) patients with compensated cirrhosis (Child-Pugh A).
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) belongs to Healthcare sector. Its net profit margin is 48.00% and weekly performance is -3.44%. On last trading day company shares ended up at $28.39.
NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), announces that it will report 2015 fourth quarter and full year financial results after market close on Thursday, March 3.
NovaBay Pharmaceuticals, Inc. (NYSEMKT:NBY) shares moved up 6.98% in last trading session and ended the day at $2.30. NBY Gross Margin is 68.80% and its return on assets is -235.60%. NovaBay Pharmaceuticals, Inc. (NYSEMKT:NBY) quarterly performance is -97.55%.
On 24 February, Legacy Reserves LP (NASDAQ:LGCY) reported Non-cash impairment expense totaled $326.3 million due to the significant decline of oil and natural gas prices during the period. General and administrative expenses, excluding acquisition costs and LTIP compensation expense, increased to $8.6 million in 2015 from $8.2 million in 2014. This increase was primarily attributable to an increase in salary and benefit expenses related to the hiring of additional personnel to manage our larger asset base partially offset by general cost reduction efforts.
On 29 February, Legacy Reserves LP (NASDAQ:LGCY) shares remains unchanged and was closed at $0.68. LGCY EPS growth in last 5 year was -11.20%. Legacy Reserves LP (NASDAQ:LGCY) year to date (YTD) performance is -61.14%.
On 16 February, Danaos Corporation (NYSE:DAC) reported Adjusted net income of $47.2 million, or $0.43 per share, for the three months ended December 31, 2015 compared to $23.5 million, or $0.21 per share, for the three months ended December 31, 2014, an increase of 100.9%. Adjusted net income of $159.5 million, or $1.45 per share, for the year ended December 31, 2015 compared to $60.0 million, or $0.55 per share, for the year ended December 31, 2014, an increase of 165.8%.
Danaos Corporation (NYSE:DAC) ended the last trading day at $4.43. Company weekly volatility is calculated as 4.19% and price to cash ratio as 5.06. Danaos Corporation (NYSE:DAC) showed a weekly performance of -3.49%.
American Midstream Partners, LP (NYSE:AMID) announced that its fourth quarter and full year 2015 fiscal results will be released after the market closes on Monday, March 7, 2016. The Partnership will host a conference call at 10:00 a.m. ET on Tuesday, March 8, 2016 to discuss results. The call will be webcast and archived on the Partnership’s website for a limited time.
American Midstream Partners, LP (NYSE:AMID) shares decreased -0.20% in last trading session and ended the day at $5.08. AMID Gross Margin is 51.80% and its return on assets is -13.30%. American Midstream Partners, LP (NYSE:AMID) quarterly performance is -40.08%.